loader
Please Wait
Applying Filters...

List of Certificates of Suitability (CEPs) for r1_cep_2011_044___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1MYLAN LABORATORIES LIMITED Hyderabad IN

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

Looking for Certificates of Suitability (CEPs) for R1-CEP 2011-044 - Rev 01 of Mylan Laboratories Limited Hyderabad In

Looking for Certificates of Suitability (CEPs) for R1-CEP 2011-044 - Rev 01 of Mylan Laboratories Limited Hyderabad In 1

20

Mylan Laboratories Limited Hyderabad In, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their significant offerings is Lamivudine, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2011-044 - Rev 01

This Chemical Type CEP, issued on October 25, 2017, remains in force until August 19, 2021, ensuring its reliability within the pharmaceutical industry.

Substance Number 2217 associated with this CEP further emphasizes